Neurocrine Biosciences, Inc. (BIT:1NBIX)
Italy · Delayed Price · Currency is EUR 120.05
0.00 (0.00%)
Last updated: Oct 31, 2025, 9:00 AM CET
Neurocrine Biosciences Market Cap
Neurocrine Biosciences has a market cap or net worth of €12.38 billion as of November 3, 2025. Its market cap has increased by 12.67% in one year.
Market Cap
12.38B
Enterprise Value
11.83B
Revenue
2.29B
Ranking
n/a
PE Ratio
33.94
Stock Price
€120.05
Market Cap Chart
Since May 23, 1996, Neurocrine Biosciences's market cap has increased from 167.33M to 12.38B, an increase of 7,298.29%. That is a compound annual growth rate of 15.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 12.38B | -7.26% |
| Dec 31, 2024 | 13.35B | 13.98% |
| Dec 29, 2023 | 11.71B | 9.01% |
| Dec 30, 2022 | 10.74B | 51.23% |
| Dec 31, 2021 | 7.10B | -2.95% |
| Dec 31, 2020 | 7.32B | -17.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UniCredit | 99.74B |
| Intesa Sanpaolo | 96.13B |
| Enel SpA | 89.08B |
| Ferrari | 61.55B |
| Assicurazioni Generali | 50.64B |
| Eni S.p.A. | 48.36B |
| Leonardo S.p.a. | 29.33B |
| Poste Italiane | 27.03B |